Study IDs new type 2 diabetes marker

11/7/2012 | Medical News Today

People who have above-average levels of SFRP4 protein in their blood have a higher risk of developing type 2 diabetes compared with those with below-average levels, research published in Cell Metabolism found. The findings suggest SFRP4, which has a part in inflammatory processes, may serve as a marker for diabetes risk and may lead to the development of new diabetes treatments, researchers said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC